By Staff writer
Julphar Gulf Pharmaceutical Industries says it plans to enter new markets,open a factory in Saudi Arabia
UAE-based pharmaceutical manufacturer Julphar is eyeing expansion into more than 30 countries around the world.
Julphar Gulf Pharmaceutical Industries said it plans to enter a number of new markets, including the opening of a factory in Saudi Arabia soon.
Factories are also planned in Bangladesh and Ethiopia, in addition to projects in Morocco, Algeria and Egypt, where medicines are being manufactured locally, Dr Hosam Badr, marketing director at Julphar told state news agency WAM.
The company’s expansion plans include 34 countries around the world, and it plans to export more than 90 percent of its products, he added.
Saudi Arabia is the biggest market for the company in the region, while Kuwait, Omar, Yemen, Iraq and Lebanon are also important, he told WAM.
He said the company is now focusing on the development of a factory to manufacture raw insulin, which will be one of only a few in the world with this capability.
Badr was speaking on the sidelines of the Global Manufacturing & Industrialisation Summit (GMIS) in Dubai.